Sandoz to acquire biosimilar CIMERLI from Coherus BioSciences to expand ophthalmology portfolio

Pallavi Madhiraju- January 24, 2024 0

In a significant development within the pharmaceutical and healthcare industry, Sandoz, a global leader in generic and biosimilar medicines, announced its strategic acquisition of the ... Read More